Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors
- PMID: 9121466
- PMCID: PMC232065
- DOI: 10.1128/MCB.17.4.2166
Peroxisome proliferator-activated receptors and retinoic acid receptors differentially control the interactions of retinoid X receptor heterodimers with ligands, coactivators, and corepressors
Abstract
As the obligate member of most nuclear receptor heterodimers, retinoid X receptors (RXRs) can potentially perform two functions: cooperative binding to hormone response elements and coordinate regulation of target genes by RXR ligands. In this paper we describe allosteric interactions between RXR and two heterodimeric partners, retinoic acid receptors (RARs) and peroxisome proliferator-activated receptors (PPARs); RARs and PPARs prevent and permit activation by RXR-specific ligands, respectively. By competing for dimerization with RXR on response elements consisting of direct-repeat half-sites spaced by 1 bp (DR1 elements), the relative abundance of RAR and PPAR determines whether the RXR signaling pathway will be functional. In contrast to RAR, which prevents the binding of RXR ligands and recruits the nuclear receptor corepressor N-CoR, PPAR permits the binding of SRC-1 in response to both RXR and PPAR ligands. Overexpression of SRC-1 markedly potentiates ligand-dependent transcription by PPARgamma, suggesting that SRC-1 serves as a coactivator in vivo. Remarkably, the ability of RAR to both block the binding of ligands to RXR and interact with corepressors requires the CoR box, a structural motif residing in the N-terminal region of the RAR ligand binding domain. Mutations in the CoR box convert RAR from a nonpermissive to a permissive partner of RXR signaling on DR1 elements. We suggest that the differential recruitment of coactivators and corepressors by RAR-RXR and PPAR-RXR heterodimers provides the basis for a transcriptional switch that may be important in controlling complex programs of gene expression, such as adipocyte differentiation.
Similar articles
-
Interactions controlling the assembly of nuclear-receptor heterodimers and co-activators.Nature. 1998 Sep 10;395(6698):199-202. doi: 10.1038/26040. Nature. 1998. PMID: 9744281
-
A regulatory role for RIP140 in nuclear receptor activation.Mol Endocrinol. 1998 Jun;12(6):864-81. doi: 10.1210/mend.12.6.0123. Mol Endocrinol. 1998. PMID: 9626662
-
Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function.Mol Cell Biol. 1998 Jun;18(6):3483-94. doi: 10.1128/MCB.18.6.3483. Mol Cell Biol. 1998. PMID: 9584188 Free PMC article.
-
The retinoid X receptor and its ligands: versatile regulators of metabolic function, cell differentiation and cell death.J Biol Regul Homeost Agents. 2003 Jan-Mar;17(1):29-45. J Biol Regul Homeost Agents. 2003. PMID: 12757020 Review.
-
PPAR gamma/RXR as a molecular target for diabetes.Recept Channels. 2001;7(4):249-58. Recept Channels. 2001. PMID: 11697231 Review.
Cited by
-
The transcription factors CREBH, PPARa, and FOXO1 as critical hepatic mediators of diet-induced metabolic dysregulation.J Nutr Biochem. 2021 Sep;95:108633. doi: 10.1016/j.jnutbio.2021.108633. Epub 2021 Mar 28. J Nutr Biochem. 2021. PMID: 33789150 Free PMC article. Review.
-
Retinoid X Receptor Antagonists.Int J Mol Sci. 2018 Aug 10;19(8):2354. doi: 10.3390/ijms19082354. Int J Mol Sci. 2018. PMID: 30103423 Free PMC article. Review.
-
The Androgen Receptor Regulates PPARγ Expression and Activity in Human Prostate Cancer Cells.J Cell Physiol. 2016 Dec;231(12):2664-72. doi: 10.1002/jcp.25368. Epub 2016 Mar 14. J Cell Physiol. 2016. PMID: 26945682 Free PMC article.
-
Peroxisome proliferator activated receptor gamma activity is low in mature primary human visceral adipocytes.Diabetologia. 2007 Jan;50(1):195-201. doi: 10.1007/s00125-006-0515-x. Epub 2006 Nov 15. Diabetologia. 2007. PMID: 17106695
-
Refocusing Peroxisome Proliferator Activated Receptor-α: A New Insight for Therapeutic Roles in Diabetes.Diabetes Metab J. 2013 Oct;37(5):326-32. doi: 10.4093/dmj.2013.37.5.326. Diabetes Metab J. 2013. PMID: 24199160 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases
Research Materials
Miscellaneous